Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 12/20 | 0.66 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.66 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.66 |
| ▸ | HTR6 | P50406 | 2/20 | 0.45 |
| ▸ | CSF1R | P07333 | 2/20 | 0.45 |
| ▸ | REN | P00797 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13677775 | 0.92 | PDE4A (0.58) | PDE4APDE4BPDE4CPDE4DCSF1R | |
| SCHEMBL13677784 | 0.92 | PDE4A (0.58) | PDE4APDE4BPDE4CPDE4DCSF1R | |
| SCHEMBL13677778 | 0.92 | PDE4A (0.57) | PDE4APDE4BPDE4CPDE4DCSF1R | |
| SCHEMBL13677790 | 0.92 | PDE4A (0.57) | PDE4APDE4BPDE4CPDE4DMAPT | |
| SCHEMBL13677783 | 0.92 | PDE4A (0.57) | PDE4APDE4BPDE4CPDE4DALDH1A1 | |
| SCHEMBL3893978 | 0.90 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DHTR6 | |
| SCHEMBL13677657 | 0.90 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DHTR6 | |
| SCHEMBL13677787 | 0.89 | PDE4A (0.62) | PDE4APDE4BPDE4CPDE4DHTR6 | |
| SCHEMBL13677774 | 0.89 | PDE4A (0.54) | PDE4APDE4BPDE4CPDE4DCSF1R | |
| SCHEMBL13677826 | 0.88 | PDE4A (0.53) | PDE4APDE4BPDE4CPDE4DCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7601742-B2 | 4-(3-Hydroxy-4-methoxyphenyl)-pyrrolidin-2-one and derivatives; reverse transcriptase inhibitors; AIDS | IRM LLC (BM) | 2009-10-13 | — | — | US | disclosed |
| US-7601742-B2 | 4-(3-Hydroxy-4-methoxyphenyl)-pyrrolidin-2-one and derivatives; reverse transcriptase inhibitors; AIDS | IRM LLC (BM) | 2009-10-13 | — | — | US | disclosed |
| US-7601742-B2 | 4-(3-Hydroxy-4-methoxyphenyl)-pyrrolidin-2-one and derivatives; reverse transcriptase inhibitors; AIDS | IRM LLC (BM) | 2009-10-13 | — | — | US | disclosed |
| US-7495016-B2 | Pyrrolidones with anti-HIV activity | IRM LLC (BM) | 2009-02-24 | — | — | US | disclosed |
| US-7495016-B2 | Pyrrolidones with anti-HIV activity | IRM LLC (BM) | 2009-02-24 | — | — | US | disclosed |
| US-7495016-B2 | Pyrrolidones with anti-HIV activity | IRM LLC (BM) | 2009-02-24 | — | — | US | disclosed |
| US-20080255136-A1 | PYRROLIDONES WITH ANTI-HIV ACTIVITY | IRM LLC (BM) | 2008-10-16 | — | — | US | disclosed |
| US-20080255136-A1 | PYRROLIDONES WITH ANTI-HIV ACTIVITY | IRM LLC (BM) | 2008-10-16 | — | — | US | disclosed |
| US-20080255136-A1 | PYRROLIDONES WITH ANTI-HIV ACTIVITY | IRM LLC (BM) | 2008-10-16 | — | — | US | disclosed |
| US-20040157859-A1 | Pyrrolidones with anti-HIV activity | IRM LLC, A DELAWARE LLC (BM) | 2004-08-12 | — | — | US | disclosed |
| WO-2004037784-A2 | PYRROLIDONES WITH ANTI-HIV ACTIVITY | IRM LLC (BM) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255136-A1 | PYRROLIDONES WITH ANTI-HIV ACTIVITY | PREP, DHPS, PDCD11 | PDE4A 1279/4885PDE4B 1650/4885PDE4C 1189/4885 |
| US-20040157859-A1 | Pyrrolidones with anti-HIV activity | PREP, DHPS, PDCD11 | PDE4A 1279/4885PDE4B 1650/4885PDE4C 1189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.